JAN 20, 2021 7:00 AM PST

Gut Bacteria's Poison Arrows Exposed

WRITTEN BY: Tara Fernandez

Bacteria armed with poison arrows and excruciating abdominal pains caused by raging inflammation in the gut. While the cause and effect of pathogenic Clostridioides difficile infections are well known, the molecular mechanisms that govern these processes are still a matter of debate. Until now, scientists have had one key piece of the puzzle: C. difficile’s toxin A triggers an innate immune response. Now, researchers at UCLA and Harvard University have unraveled just how the toxin does this, shedding more light on the inner workings of this potentially deadly infection.

Published in the journal Gastroenterology, the team, led by Ciarán P. Kelly, took a closer look at the molecular structure of Toxin A using analytical tools powered by machine learning as well as synchrotron small-angle X-ray scattering. They were able to zero in on the precise segment of Toxin A that crosses over the cell membrane and attaches to endosomes, cellular organelles that regulate the trafficking of proteins and lipids. 

The gut presents an extremely hostile environment for bacteria. Not many can survive the hydrochloric acid present in gastric juice. What has baffled scientists is how C. difficile’s toxin A protein can withstand these harsh conditions and induce inflammation within the gut. Kelly and colleagues found that toxin A is degraded into fragments within the acidic, protease-rich gastric juice. Fascinatingly, the fragments remained potent, organizing their DNA into geometrically-ordered structures that resembled crystals. These were able to activate and amplify immune responses via the toll-like receptor 9. This receptor recognizes bacterial and viral DNA containing specific chemical motifs. This process then unleashes the excessive inflammation in the gut.

C. difficile infections are a common healthcare-associated infection costing the U.S. around $1.5 billion annually. Certain medications and a recent history of food poisoning are thought to increase the risk of infections outside of a hospital setting. An uptick in the global rates of infections means that there is an urgent need for improved methods of treating or preventing C. difficile infections. This new understanding of how toxin A exerts its devastating effects is a significant step in the right direction.

 

 

Sources: Gastroenterology, New England Journal of Medicine.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 12, 2020
Drug Discovery & Development
Researchers Solve Key Problem for Cancer Immunotherapy
OCT 12, 2020
Researchers Solve Key Problem for Cancer Immunotherapy
Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promi ...
NOV 02, 2020
Immunology
New Cancer Drug Reboots Stalled Immunotherapies
NOV 02, 2020
New Cancer Drug Reboots Stalled Immunotherapies
In contrast to traditional chemotherapies, immunotherapies reprogram the patient’s own immune system to fight tumo ...
DEC 02, 2020
Immunology
A Shingles Vaccine for Cancer Patients
DEC 02, 2020
A Shingles Vaccine for Cancer Patients
Receiving a vaccine (usually in the form of an inactivated pathogen) triggers an immune response without the symptoms of ...
DEC 08, 2020
Immunology
Drug Targets Cold Tumors' Achilles Heel
DEC 08, 2020
Drug Targets Cold Tumors' Achilles Heel
Immunotherapies have emerged as a powerful treatment modality for cancer. They join chemotherapy, surgery, radiotherapy, ...
DEC 29, 2020
Immunology
Cancer-Killing Viruses Enter in Stealth Mode, Penetrate Immune Barrier
DEC 29, 2020
Cancer-Killing Viruses Enter in Stealth Mode, Penetrate Immune Barrier
Viruses that when administered to patients preferentially attack and kill cancer cells, leaving normal tissues unscathed ...
FEB 18, 2021
Immunology
Protective COVID Antibodies Found in Breast Milk
FEB 18, 2021
Protective COVID Antibodies Found in Breast Milk
University of Rochester researchers analyzing breast milk samples from mothers with COVID-19 found that it doesn’t ...
Loading Comments...